valor de las acciones
Competidores
| Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
760.00 | -48.06% | -26.74% | 684,308.09 | 0.67% | 2.63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
883.20 | 1.22% | 22.21% | 3,934,511.59 | 1.06% | 18.5% |
|
NYSE:JNJ
Johnson & Johnson
|
149.91 | 0% | 0% | 360,785.28 | 3.31% | 2.71% |
|
NYSE:MRK
Merck
|
130.06 | -9.24% | 4.07% | 329,416.79 | 2.37% | -19.03% |
|
NYSE:ABBV
AbbVie
|
160.75 | -20.35% | -9.82% | 283,863.25 | 3.87% | 7.03% |
|
LSE:AZN
AstraZeneca PLC
|
123.70 | 16.41% | 38.64% | 191,764.07 | 2.01% | 15.98% |
|
SWX:NOVN
Novartis
|
92.32 | 9.38% | 22.91% | 188,370.32 | 3.64% | 4.67% |
|
NasdaqGS:AMGN
Amgen
|
310.15 | -11.6% | -2.74% | 166,375.22 | 2.88% | 5.31% |
|
LSE:GSK
GSK
|
18.00 | 5.94% | 21.55% | 73,384.28 | 3.26% | 0.79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.94 | 58.46% | 68.59% | 91,097.88 | 5.36% | 13.54% |
|
ASX:CSL
CSL
|
279.18 | 22.87% | 43.8% | 134,914.5 | 1.29% | 7.18% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
65.96 | 24.12% | 33.63% | 82,176.48 | 4.77% | 0.15% |
|
NYSE:MMM
3M
|
98.93 | 67.8% | 83.94% | 54,744.03 | 6.21% | -2.45% |
|
NasdaqGS:MRNA
Moderna
|
117.31 | -,112.14% | -,108.38% | 44,957.85 | 0% | 0% |
|
SWX:LONN
Lonza Group
|
526.20 | -28.1% | -12.97% | 37,947.75 | 0.76% | 0.68% |
|
NYSE:CTVA
Corteva
|
57.48 | 16.07% | 36.84% | 40,062.18 | 1.11% | 17.11% |
|
XTRA:BEI
Beiersdorf
|
147.25 | -3.19% | 7.7% | 32,957.35 | 0.69% | 3.11% |
|
NasdaqGS:BIIB
Biogen
|
221.50 | -11.75% | 3.9% | 32,249.71 | 0% | -10.89% |
|
XTRA:BAYN
Bayer
|
28.96 | 65.34% | 81.47% | 28,446.09 | 0.38% | 1.47% |
|
CPSE:COLO B
Coloplast A/S
|
845.20 | 18.25% | 36.71% | 190,034.82 | 2.48% | 4.41% |
